UNCLASSIFIED

advertisement

UNCLASSIFIED

Exhibit R-2 , RDT&E Budget Item Justification: PB 2014 Navy

APPROPRIATION/BUDGET ACTIVITY

1319: Research, Development, Test & Evaluation, Navy

BA 3: Advanced Technology Development (ATD)

R-1 ITEM NOMENCLATURE

PE 0603729N:

COST ($ in Millions)

Total Program Element

2914: Warfighter Protection Adv

Tech

All Prior

Years FY 2012 FY 2013 #

0.000

55.867

0.000

17.167

3.880

3.880

FY 2014

Base

4.760

4.760

FY 2014

OCO

9999: Congressional Adds 0.000

38.700

0.000

0.000

# FY 2013 Program is from the FY 2013 President's Budget, submitted February 2012

## The FY 2014 OCO Request will be submitted at a later date

##

-  

-  

-  

Warfighter Protection Adv Tech

FY 2014

Total

4.760

4.760

0.000

DATE: April 2013

FY 2015 FY 2016 FY 2017 FY 2018

4.838

4.838

0.000

4.812

4.812

0.000

4.894

4.894

0.000

4.982 Continuing Continuing

4.982 Continuing Continuing

0.000

Cost To

Complete

0.000

Total

Cost

38.700

Note

FY 2013 funding associated with Future Naval Capability (FNC) efforts are transferring to a new Program Element titled Future Naval Capabilities Advanced

Technology Development (PE 0603673N). This is to enhance the visibility of the FNC Program by providing an easily navigable overview of all 6.3 FNC investments in a single location.

A. Mission Description and Budget Item Justification

The efforts described in this Program Element (PE) are based on investment directions as defined in the Naval S&T Strategic Plan approved by the S&T Corporate

Board (Sep 2011). This strategy is based on needs and capabilities from Navy and Marine Corps guidance and input from the Naval Research Enterprise (NRE) stakeholders (including the Naval enterprises, the combatant commands, the Chief of Naval Operations (CNO), and Headquarters Marine Corps). It provides the vision and key objectives for the essential science and technology efforts that will enable the continued supremacy of U.S. Naval forces in the 21st century. The Strategy focuses and aligns Naval S&T with Naval missions and future capability needs that address the complex challenges presented by both rising peer competitors and irregular/asymmetric warfare.

This program supports the development and demonstration of field medical equipment and technologies to improve warfighter safety and to enhance personnel performance under adverse conditions. Navy investment in these areas is essential because Navy/USMC mission needs are not adequately addressed by the civilian sector or other Federal agencies. These projects support funds future capabilities within the Force Health Protection Program, a Future Naval Capability (FNC) that will provide technology options for the future Navy and Marine Corps by reducing morbidity and mortality when casualties occur.

Due to the number of efforts in this PE, the programs described herein are representative of the work included in this PE.

PE 0603729N: Warfighter Protection Adv Tech

Navy

UNCLASSIFIED

Page 1 of 7 R-1 Line #23

UNCLASSIFIED

Exhibit R-2 , RDT&E Budget Item Justification: PB 2014 Navy

APPROPRIATION/BUDGET ACTIVITY

1319: Research, Development, Test & Evaluation, Navy

BA 3: Advanced Technology Development (ATD)

B. Program Change Summary ($ in Millions)

Previous President's Budget

Current President's Budget

Total Adjustments

• Congressional General Reductions

• Congressional Directed Reductions

• Congressional Rescissions

• Congressional Adds

• Congressional Directed Transfers

• Reprogrammings

• SBIR/STTR Transfer

• Program Adjustments

FY 2012

56.819

55.867

-0.952

-  

-  

-  

-  

-  

-0.221

-0.731

0.000

R-1 ITEM NOMENCLATURE

PE 0603729N:

FY 2013

3.880

3.880

0.000

-  

-  

-  

-  

-  

0.000

0.000

0.000

Warfighter Protection Adv Tech

FY 2014 Base

4.766

4.760

-0.006

-0.006

DATE:

FY 2014 OCO

-  

-  

-  

-  

Congressional Add Details ($ in Millions, and Includes General Reductions)

Project: 9999: Congressional Adds

Congressional Add: CW Bill Young Marrow Donor Program

Congressional Add: Naval Special Warfare Performance and Injury Prevention Program

Congressional Add Subtotals for Project: 9999

April 2013

FY 2014 Total

FY 2012

31.500

7.200

38.700

4.766

4.760

-0.006

-0.006

FY 2013

-  

-  

0.000

Congressional Add Totals for all Projects 38.700

0.000

Change Summary Explanation

Technical: Not applicable.

Schedule: Not applicable.

PE 0603729N: Warfighter Protection Adv Tech

Navy

UNCLASSIFIED

Page 2 of 7 R-1 Line #23

UNCLASSIFIED

Exhibit R-2A , RDT&E Project Justification: PB 2014 Navy

APPROPRIATION/BUDGET ACTIVITY

1319: Research, Development, Test & Evaluation, Navy

BA 3: Advanced Technology Development (ATD)

R-1 ITEM NOMENCLATURE

PE 0603729N: Warfighter Protection Adv

Tech

COST ($ in Millions)

2914: Warfighter Protection Adv

Tech

All Prior

Years FY 2012 FY 2013

0.000

17.167

#

3.880

FY 2014

Base

4.760

FY 2014

OCO

# FY 2013 Program is from the FY 2013 President's Budget, submitted February 2012

## The FY 2014 OCO Request will be submitted at a later date

##

-  

FY 2014

Total

4.760

PROJECT

DATE: April 2013

2914: Warfighter Protection Adv Tech

FY 2015 FY 2016 FY 2017 FY 2018

4.838

4.812

4.894

Cost To

Complete

Total

Cost

4.982 Continuing Continuing

A. Mission Description and Budget Item Justification

This program supports the development and demonstration of field medical equipment, diagnostic capabilities and treatments; technologies to improve warfighter safety and to enhance personnel performance under adverse conditions; and systems to prevent occupational injury and disease in hazardous, deployment environments.

Navy investment in these areas is essential because Navy/USMC mission needs are not adequately addressed by the civilian sector or other Federal agencies. For example, civilian emergency medicine does not address casualty stabilization during long transit times to definitive care. The NIH focuses on the basic science of disease processes and not product development. Programs are coordinated with other Services through the Armed Services Biomedical Research Evaluation and

Management (ASBREM) Committee to prevent duplication of effort. This project funds the Force Health Protection program a Future Naval Capability (FNC)that will provide technology options for future Navy and Marine Corps capabilities and supports the "Sea Warrior" component of the Naval Transformation Roadmap, medical logistics aspects of "Sea Basing" and expeditionary force medical support associated with "Sea Strike".

B. Accomplishments/Planned Programs ($ in Millions)

Title: CASUALTY CARE AND MANAGEMENT

Description: The goal of Casualty Care and Management is to maximize the continuum of care with lifesaving interventions as close to the battlespace as possible. This is in an increasingly lethal battlespace, with reduced infrastructure and logistics.

FY 2012

8.290

FY 2013

0.000

FY 2014

0.000

The decrease of funding from FY 2012 to FY 2013 is the result of the transfer of resources from this R2 activity to a new FNC R2 activity titled Force Health Protection. Efforts in this R2 activity have been continued from FY 2012 to FY 2013 into the new R2 activity to support all FNC program EC Investments.

FY 2012 Accomplishments:

- Continued study to demonstrate selectivity/specificity of biomarkers for mild & moderate RNT in appropriate pre-clinical model.

- Continued efforts to develop advanced technologies for First Responders.

- Continued efforts to develop advanced technologies to support the Forward Resuscitative Surgical System/ Expeditionary

Resuscitative Surgical Systems (FRSS/ERSS).

- Continued program to develop advanced technologies to support En Route Care of casualties.

- Continued preclinical study to evaluate use of vasopressin to manage traumatic brain injury (TBI).

- Continued efforts to develop prototype technology for closed-loop resuscitation for USMC En Route Care system.

PE 0603729N: Warfighter Protection Adv Tech

Navy

UNCLASSIFIED

Page 3 of 7 R-1 Line #23

UNCLASSIFIED

Exhibit R-2A , RDT&E Project Justification: PB 2014 Navy

APPROPRIATION/BUDGET ACTIVITY

1319: Research, Development, Test & Evaluation, Navy

BA 3: Advanced Technology Development (ATD)

R-1 ITEM NOMENCLATURE

PE 0603729N: Warfighter Protection Adv

Tech

PROJECT

2914:

B. Accomplishments/Planned Programs ($ in Millions)

- Continued program to examine comorbidity of traumatic brain injury. (Continuation of similar effort funded in Healthy and Fit

Force Activity).

- Continued pharmacologic research studies to support an FDA Investigational New Drug (IND) application.

- Continued efforts to develop advanced technologies to support Rapid Blood Treatment. (Previously identified as First

Responder).

- Continued efforts to develop advanced technologies to support Advanced Forward Care. (Previously identified as FRSS/ERSS).

- Continued efforts to develop advanced technologies to support Warfighter Restoration. (Previously identified as En Route Care).

- Continue development of multifunctional blood substitute program.

- Initiate development of the Automated Critical Care System (ACCS).

Title: CASUALTY PREVENTION

Description: Casualty Prevention includes protecting the warfighter from environmental, occupational and battlefield threats.

DATE: April 2013

Warfighter Protection Adv Tech

FY 2012

6.039

FY 2013

0.000

FY 2014

0.000

The decrease of funding from FY 2012 to FY 2013 is the result of the transfer of resources from this R2 activity to a new FNC R2 activity titled Force Health Protection. Efforts in this R2 activity have been continued from FY 2012 to FY 2013 into the new R2 activity to support all FNC program EC Investments.

FY 2012 Accomplishments:

- Continued efforts to mitigate the effects of environmental and other threats to health.

- Continued efforts to reduce operational injuries.

- Continued research to determine the safety and efficacy of perfluorocarbons in treating decompression sickness and arterial gas embolism.

- Continued development of tools to prevent psychological stress and PTSD.

- Continued efforts to model head and neck injuries due to accelerated forces; operational injuries.

- Continued research to enhance force readiness by mitigating the impact of environmental stressors.

- Continued development of Human Injury and Treatment (HIT) model to assess personnel survivability, optimal personnel treatment, and restoration of ship operational capabilities.

- Initiated development of Perfluorocarbon-based treatments for explosive blast injuries and hypoxia and lung damage from extreme environments.

Title: NAVAL NOISE-INDUCED HEARING LOSS (NIHL)

Description: The goal of this program is to reduce the incidence of NIHL by nearly 100%. This program employs a total systems engineering approach that includes advancements in medical technology, jet engine physics, personal protective equipments, and mitigation analyses.

2.838

3.880

4.760

PE 0603729N: Warfighter Protection Adv Tech

Navy

UNCLASSIFIED

Page 4 of 7 R-1 Line #23

UNCLASSIFIED

Exhibit R-2A , RDT&E Project Justification: PB 2014 Navy

APPROPRIATION/BUDGET ACTIVITY

1319: Research, Development, Test & Evaluation, Navy

BA 3: Advanced Technology Development (ATD)

B. Accomplishments/Planned Programs ($ in Millions)

R-1 ITEM NOMENCLATURE

PE 0603729N:

Tech

Warfighter Protection Adv

PROJECT

2914:

FY 2012 to FY 2013 funding is due to an increase in support of the research efforts to Jet Noise Reduction Initiatives.

FY 2012 Accomplishments:

- Continued advanced research in medical prevention and treatment of NIHL and tinnitus (ringing in the ears).

- Continued advanced research to reduce noise at the source, jet engine quieting and flight deck noise reduction.

- Continued advanced research to improve personal protective equipment technology.

- Continued advanced research to study the incidence and susceptibility of NIHL and tinnitus, and to evaluate mitigation strategies.

- Completed research to reduce noise at the source, i.e., shipboard and flight deck noise reduction.

FY 2013 Plans:

Noise Induced Hearing Loss

- Continue all efforts of FY 2012, less those noted as completed above.

Regenerative Medicine

- Continue all efforts of FY 2012, less those noted as completed above.

FY 2014 Plans:

Noise Induced Hearing Loss

- Continue all efforts of FY 2013.

Regenerative Medicine

- Continue all efforts of FY 2013.

- Initiated program, with Army, in regenerative medicine (Armed Forces Institute for Regenerative Medicine (AFIRM).

Accomplishments/Planned Programs Subtotals

C. Other Program Funding Summary ($ in Millions)

N/A

Remarks

D. Acquisition Strategy

N/A

DATE: April 2013

Warfighter Protection Adv Tech

FY 2012

17.167

FY 2013

3.880

FY 2014

4.760

PE 0603729N: Warfighter Protection Adv Tech

Navy

UNCLASSIFIED

Page 5 of 7 R-1 Line #23

UNCLASSIFIED

Exhibit R-2A , RDT&E Project Justification: PB 2014 Navy

APPROPRIATION/BUDGET ACTIVITY

1319: Research, Development, Test & Evaluation, Navy

BA 3: Advanced Technology Development (ATD)

R-1 ITEM NOMENCLATURE

PE 0603729N: Warfighter Protection Adv

Tech

PROJECT

2914:

DATE: April 2013

Warfighter Protection Adv Tech

E. Performance Metrics

Efforts within this PE are measured at two levels. At the lower level, each is measured against technical and financial milestones on a monthly basis. Annually, each project is reviewed in depth for technical and transition performance by the Chief of Naval Research (CNR).

PE 0603729N: Warfighter Protection Adv Tech

Navy

UNCLASSIFIED

Page 6 of 7 R-1 Line #23

UNCLASSIFIED

Exhibit R-2A , RDT&E Project Justification: PB 2014 Navy

APPROPRIATION/BUDGET ACTIVITY

1319: Research, Development, Test & Evaluation, Navy

BA 3: Advanced Technology Development (ATD)

R-1 ITEM NOMENCLATURE

PE 0603729N: Warfighter Protection Adv

Tech

COST ($ in Millions)

9999: Congressional Adds

All Prior

Years FY 2012 FY 2013

0.000

38.700

#

0.000

FY 2014

Base

0.000

FY 2014

OCO ##

-  

# FY 2013 Program is from the FY 2013 President's Budget, submitted February 2012

## The FY 2014 OCO Request will be submitted at a later date

FY 2014

Total

0.000

0.000

0.000

PROJECT

0.000

DATE: April 2013

9999: Congressional Adds

FY 2015 FY 2016 FY 2017 FY 2018

0.000

Cost To

Complete

Total

Cost

0.000

38.700

A. Mission Description and Budget Item Justification

Congressional Interest Items not included in other Projects.

B. Accomplishments/Planned Programs ($ in Millions)

Congressional Add: CW Bill Young Marrow Donor Program

FY 2012 Accomplishments: This effort continues the research of the C.W. Bill Young Bone Marrow Donor

Recruitment and Research Program.

Congressional Add: Naval Special Warfare Performance and Injury Prevention Program

FY 2012 Accomplishments: This effort continued the data collection at Naval Special Warfare Group 2 (Little

Creek) and Naval Special Warfare Group 4, Special Boat Team 22 (Stennis), Seal Qualification Training

(Coronado) to strategically maximize human capital by reducing the rate of unintentional musculoskeletal injury, sharpen battlefield performance, optimize military readiness, extend the tactical life cycle of the Operator, and enhance quality of life of the Operator after service. Established human performance laboratory at Coronado.

Congressional Adds Subtotals

C. Other Program Funding Summary ($ in Millions)

N/A

Remarks

FY 2012 FY 2013

31.500

-  

7.200

38.700

-  

0.000

D. Acquisition Strategy

N/A

E. Performance Metrics

Congressional Interest Items not included in other Projects.

PE 0603729N: Warfighter Protection Adv Tech

Navy

UNCLASSIFIED

Page 7 of 7 R-1 Line #23

Download